Zhongmei Healthcare Group Limited announced that it has received CNY 63.8 million in a round of funding from a new investor, Carlyle Asia Partners IV, a fund managed by The Carlyle Group LP in January 2016. The investor acquired 15.7% stake in the transaction. The transaction is a pre-IPO transaction.

O'Melveny & Myers LLP acted as a legal advisor to the company.